Lisi S.A.: history, ownership, mission, how it works & makes money

From its founding as a French watchmaker in 1777 to a modern industrial group rebranded in 2002, Lisi S.A. has built a global footprint of 42 production sites across 13 countries and about 10,262 employees, delivering a record consolidated revenue of €1.79 billion in 2024 as it serves aerospace, automotive and medical markets through LISI Aerospace, LISI Automotive and LISI Medical; today Lisi is listed on Euronext Paris (FII) with a market cap near €2.26 billion, 45.72 million shares outstanding and a P/E of 36.67, while its sales mix-57.4% aeronautics, 32.3% automotive and 10.3% medical-underpins a performance where the aerospace division alone generated €1.03 billion in 2024 (up 22.8%), automotive €579.7 million and medical €185.3 million, and where strategic moves such as exclusive talks in July 2025 with SK Capital to acquire LISI MEDICAL and ongoing ESG progress (39% carbon reduction vs 2019, photovoltaic installations on five sites) shape its trajectory amid confirmed 2025 targets and vigilance around geopolitical and currency risks.

Lisi S.A. (FII.PA): Intro

• Founding year: 1777 (watchmaking origins)
• Rebranded: 2002 (from GFI Industries to Lisi S.A.)
• Global footprint: 42 production sites across 13 countries (end of 2024)
• Key sectors served: aerospace, automotive, medical

• Core activities: design, manufacturing and assembly of fasteners, precision components and sub-assemblies.
• End markets: aerospace (airframe fasteners, structural parts), automotive (safety-critical fasteners, assembled modules), medical (implantable devices, surgical components).
• Revenue generation: product sales, long-term supply contracts, engineering and assembly services, aftermarket and spare parts.

• Scale and diversification: multiple sites and countries reduce customer concentration and geographic risk.
• Value-added services: moving up the value chain into assemblies and engineered solutions increases margins versus pure-component sales.
• Long-term contracts with OEMs: multi-year programs in aerospace and automotive provide predictable revenue streams.
• Portfolio management: strategic disposals/acquisitions such as the 2025 talks regarding LISI MEDICAL to sharpen focus or grow segments.

Lisi S.A. (FII.PA): History

• Listed market: Euronext Paris (ticker: FII); secondary listing Frankfurt (ticker: LI3).
• Market capitalization: approximately €2.26 billion (as of 12-Dec-2025).
• Shares outstanding: 45.72 million.
• P/E ratio: 36.67.
• Dividend yield: 0.79% (most recent ex-dividend: 30-Apr-2025).
• Beta: 1.14 (moderate volatility versus market).

• Public float: majority of shares accessible to institutional and retail investors via Euronext and Frankfurt listings.
• Institutional ownership: significant institutional participation typical for mid-cap industrials (mix of domestic and international funds).
• Management and historical family interests: historically present but reduced through public listings and share issuances.

• Revenue model: product sales (fasteners, precision components), engineering services, integrated assembly solutions and aftermarket parts.
• Customer concentration: high exposure to aerospace and automotive OEMs-contracts and certifications create durable revenue streams.
• Margin levers: engineering content per unit, scale in high-precision production, geographic footprint optimization and vertical integration for treatments/assemblies.
• Capital allocation: reinvestment in automated manufacturing, selective acquisitions to augment capabilities, and shareholder returns via dividends (yield 0.79%).

Lisi S.A. (FII.PA): Ownership Structure

• Mission and values: sustainable innovation, operational excellence, customer proximity, and responsible growth.
• Sector focus: aerospace (fastening systems, safety-critical parts), automotive (precision components, fastening systems), medical (implantable and instrumentation components).
• Recognitions: Grand Laureate of the Year at 'Future of Finance'; Deloitte Best Managed Companies label (three consecutive years).
• ESG progress: ESG ratings improved for the fourth consecutive year; photovoltaic panels installed on 5 sites across 5 countries; carbon emissions reduced by 39% vs 2019 for Scopes 1, 2 and partial 3.

• Installed renewable capacity: photovoltaic systems active on 5 sites in 5 countries (production reduces site energy draw and lowers scope 2 emissions).
• R&D and capex intensity: ~3-4% of revenue invested annually in R&D and process modernization.
• Awards & governance: sustained recognition for governance and management quality supports access to institutional capital.

• High-value components and fastening systems sold to OEMs and Tier-1 suppliers (long-term contracts, engineering & qualification cycles create barriers to entry).
• Aftermarket and repair channels in aerospace and automotive provide recurring revenues and spare parts margins.
• Value-added services: design-for-manufacturing, surface treatments, assembly kits, logistics and vendor-managed inventory.

Lisi S.A. (FII.PA): Mission and Values

• LISI Aerospace - structural fasteners, installation tools, precision assemblies (57.4% of net sales; ranks third worldwide in aeronautics).
• LISI Automotive - fasteners, motor mounts, high‑precision securing systems for powertrain and body applications (32.3% of net sales).
• LISI Medical - orthopedic and trauma implants, instrumentation and related services (10.3% of net sales).

• 42 production sites across 13 countries.
• Approximately 10,262 employees as of 2024.
• Global client base with geographically distributed net sales.

• Structural fasteners and cold‑formed parts for airframes and engines (core aerospace revenue).
• Installation tools and precision assemblies that capture aftermarket and OEM service revenue.
• Automotive components including fasteners and motor mounts tied to vehicle production cycles.
• Medical implants and instruments sold to hospitals and distributors; value capture via design, certification and lifecycle support.

• Product sales to OEMs and Tier‑1 suppliers in aerospace and automotive markets (volume + long‑term contracts for continuity).
• Specialized, high‑value components (fasteners, implants) that command technical premiums and recurring aftermarket/service revenues.
• Geographic diversification spreading exposure across Europe, North America and Asia.
• Operational scale from 42 production sites enabling cost efficiencies and proximity to customers.

Lisi S.A. (FII.PA): How It Works

• Primary revenue streams: engineered fasteners, safety-critical assemblies, surface treatments and integrated sub-assemblies.
• Key customers: global aeronautics OEMs and supply chains (notably Airbus ecosystem), major automotive manufacturers and medical device companies.
• Geographic footprint: multi-continent manufacturing and service centers enabling proximity to major industrial hubs and customers.

• Product design & qualification - collaboration with OEMs to meet specifications and obtain certifications that command higher margins.
• Volume manufacturing - series production contracts provide predictable revenue and utilization-driven profitability.
• Aftermarket & services - maintenance, repair, surface treatments and spare parts extend revenue streams beyond initial sales.
• New product development - program wins and industrialization convert R&D into base-load production revenue over multi-year cycles.

• Aeronautics: Strong civil aeronautics recovery and deep integration in the Airbus ecosystem drove a 22.8% revenue jump to €1.03bn in 2024.
• Automotive: Global vehicle production slowdowns reduced automotive sales by 5.0% to €579.7m, though program wins (~€71.0m) bolster future backlog.
• Medical: Modest growth to €185.3m (+1.8%) with supply-chain headwinds; management expects recovery in H2 2025.
• Portfolio balance: diversified exposure reduces single-market cyclicality and supports cash generation even when one sector softens.

• Scale in precision machining and surface treatment lowers unit cost across programs.
• Program qualification and long-term contracts create visibility on volumes and margins.
• Value-added assemblies and integrated solutions move the company up the value chain versus commodity fasteners.
• Continuous improvement and capacity allocation adjust fixed-cost absorption with demand swings.

Lisi S.A. (FII.PA): How It Makes Money

Lisi S.A. generates revenue through three core activities-fasteners & safety systems for aeronautics, specialized components for the automotive and industrial sectors, and a medical implant & instrument business-leveraging scale, engineering expertise and global manufacturing footprint to capture value across high-added-value niches.

• Leading aeronautics supplier: aeronautics activities represent a dominant share of net sales (57.4%), positioning the group as the third‑ranked supplier worldwide in that market.
• Diversified industrial & automotive operations: components, machining and assembly contracts with OEMs and tier‑1 suppliers provide recurring revenues and long-term contracts.
• Medical division (LISI MEDICAL): specialized implants and instruments sold to hospitals and medtech distributors; strategic transactions in 2025 aim to accelerate value capture.

• Geographic diversification: multi‑site presence reduces single‑market exposure and supports just‑in‑time supply to international OEMs.
• Value capture levers: engineered-product margins, long‑term OEM contracts, aftermarket & service revenues, and selective M&A to densify niches.
• Risk management focus: active monitoring of customs policy shifts, currency volatility and geopolitical disruptions to protect margins and working capital.

With a strengthened balance sheet and strategic initiatives underway, Lisi S.A. aims to consolidate global leadership in its chosen niches while maintaining the confirmed 2025 targets and executing the LISI MEDICAL transaction. For additional context on the group's guiding principles, see Mission Statement, Vision, & Core Values (2026) of Lisi S.A.